the european infarction study ( eis ) was a multicentre , double-blind , randomized study comparing the effect on survival , cardiac mortality and non-fatal cardiac events of oxprenolol slow release 160 mg b.i.d . with placebo in 1,741 patients aged 35 to 69 years surviving acute myocardial infarction .
C0018787
cardiac
C0155626
acute myocardial infarction